ActiveMSers Forums  

Go Back   ActiveMSers Forums > Forums > Dave's SCT Journey

Thread Tools Display Modes
Old 02-04-2020, 02:40 PM
ActiveMSers's Avatar
ActiveMSers ActiveMSers is online now
Dave @ ActiveMSers
Join Date: Jun 2008
Location: Albuquerque, NM
Posts: 4,052
Default Editorial: Immune Profile After HSCT for autoimmune diseases: where do we stand?

Front Immunol. 2019; 10: 3044.
Published online 2020 Jan 9. doi: 10.3389/fimmu.2019.03044
PMCID: PMC6962345
PMID: 31993057

Editorial: Immune Profile After Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: Where Do We Stand?

Kelen Cristina Ribeiro Malmegrim, Antoine Toubert, et al

Autologous hematopoietic stem cell transplantation (AHSCT) induces long-term remission in autoimmune diseases (AD) without further use of immunosuppression (1, 2). Recently, randomized trials have proven greater efficacy of AHSCT when compared to conventional therapies for multiple and systemic sclerosis (36). However, despite the overall positive outcomes, subgroups of patients reactivate the AD after AHSCT due to reasons not yet completely understood, indicating that additional specific immunological interventions may still be required to improve or sustain therapeutic efficacy of AHSCT.

This Frontiers Research Topic, combines reviews, opinions, and original research from the most active researchers in the field of AHSCT for AD. Here, clinical outcomes and immune mechanisms of AHSCT, as well as insights for future studies are presented in the setting of different AD.

Dave Bexfield
Reply With Quote

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump

All times are GMT -4. The time now is 08:27 PM.

Powered by vBulletin® Version 3.7.0
Copyright ©2000 - 2020, Jelsoft Enterprises Ltd.